Home Pfizer May Cause Researchers Short-Term Pain, Long-Term Gain
 

Keywords :   


Pfizer May Cause Researchers Short-Term Pain, Long-Term Gain

2015-11-27 21:21:48| Biotech - Topix.net

The marriage of two of the biggest U.S. drugmakers is not without consequences for the rest of the health-care supply chain, particularly for the firms that handle their outsourced research and development work. Pfizer Inc. and Allergan Plc agreed Monday to a $160 billion deal that gives Pfizer a suite of new therapeutic development areas like eye care, women's health and antibiotics.

Tags: gain pain researchers pfizer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »